Study of protection by recombinant fowl poxvirus expressing C-terminal nucleocapsid protein of infectious bronchitis virus against challenge.
about
A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.Characterization of newly emerging Newcastle disease virus isolates from the People's Republic of China and Taiwan.Oral and nasal DNA vaccines delivered by attenuated Salmonella enterica serovar Typhimurium induce a protective immune response against infectious bronchitis in chickens.Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus.The epitope study on the SARS-CoV nucleocapsid protein.
P2860
Study of protection by recombinant fowl poxvirus expressing C-terminal nucleocapsid protein of infectious bronchitis virus against challenge.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Study of protection by recombi ...... hitis virus against challenge.
@en
Study of protection by recombi ...... hitis virus against challenge.
@nl
type
label
Study of protection by recombi ...... hitis virus against challenge.
@en
Study of protection by recombi ...... hitis virus against challenge.
@nl
prefLabel
Study of protection by recombi ...... hitis virus against challenge.
@en
Study of protection by recombi ...... hitis virus against challenge.
@nl
P2093
P356
P1433
P1476
Study of protection by recombi ...... chitis virus against challenge
@en
P2093
P304
P356
10.2307/1592973
P577
2001-04-01T00:00:00Z